# A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer

> **NCT01147484** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 47 (actual)

## Conditions studied

- Recurrent Breast Cancer

## Interventions

- **DRUG:** Foretinib

## Key facts

- **NCT ID:** NCT01147484
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-02
- **Primary completion:** 2014-12-14
- **Final completion:** 2015-02-13
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147484, "A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01147484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*